Biotech | February 24, 2022
Aadi Bioscience launches Fyarro in the USA
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Chandy was the president of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation, and purification technologies. Previously, she was chief marketing officer at the Dow Chemical Company and Rohm and Haas Corporation
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
New biotechnology product aims to be world's fastest automatic sanitary solution
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Subscribe To Our Newsletter & Stay Updated
